To cite this paper use one of the standards below:
This research aimed design, synthesize and investigated the LQFM275 – designed from celecoxib and darbufelone through molecular hybridization strategy. Swiss female mice (n=10) received (p.o.) vehicle (10 mL/kg), celecoxib (300 μmol/kg) or LQFM275 (75, 150 and 300 μmol/kg) to executed the acetic acid-induced abdominal writhing test. In another set, Swiss female mice (n=10) received (p.o.) vehicle, indomethacin (28 μmol/kg) or LQFM275 (300 μmol/kg) or morphine (17,6 μmol/kg, s.c.) to performed formalin-induced pain test (0-5 min: 1st phase – neurogenic pain and 15-30 min: 2nd phase – inflammatory pain). LQFM275 reduced the number of abdominal writhing at dose of 150 and 300 μmol/kg (89 ± 7 and 84 ± 1 vs. 118 ± 2, respectively) and at dose of 300 μmol/kg the paw licking time in the second phase of formalin test (65 ± 8 vs. 151 ± 16) compared to vehicle. Therefore, LQFM275 attenuated the pain reaction possible by modulating the inflammatory process.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper